MICHAEL RUA: Open Payments
NPI 1851321574 · SMITHFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,735 in 163 payments from 27 companies in 2025. Trend: 2023 $3,364 · 2024 $3,965 · 2025 $2,735
Food & beverage: $2,735
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $536 |
| AstraZeneca Pharmaceuticals LP | 7 | $404 |
| PFIZER INC. | 24 | $337 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $204 |
| GlaxoSmithKline, LLC. | 14 | $194 |
| ABBVIE INC. | 14 | $152 |
| Lilly USA, LLC | 10 | $140 |
| Daiichi Sankyo Inc. | 4 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Azurity Pharmaceuticals, Inc. | 4 | $73 |
Products named: FASENRA, JARDIANCE, TRELEGY ELLIPTA, Wegovy, MOUNJARO, NURTEC ODT, QULIPTA, INJECTAFER.
Industry payments across PA — which companies pay providers there.
